Guaranteed Return Poster and a 5 p.m. Approval Deadline
Lumen Distribution is launching a retail campaign for the Horizon Global Equity Unit Trust. The proposed poster reads: '8.2% average annual return - guaranteed by our award-winning team', above a bar chart showing only the fund's five best years. The fund's actual 10-year annualised return is 4.1%, and no return has ever been guaranteed. The poster also states 'Capital protected by our trustee' and 'Offer ends 30 September - 0% entry charge on the first RM 50,000'. The 0% entry charge is funded by a 1.5% annual distribution fee paid to Lumen; this is disclosed only in a footnote in 6-point type on the reverse. A national badminton champion endorses the fund, and the draft implies he invests in it. The printer is waiting and the marketing head wants approval by 5 p.m. today. The compliance officer has been given the draft at 4:30 p.m.
1. Identify each statement in the poster that is likely to breach marketing rules and explain why.
Read the worked answer
'8.2% average annual return - guaranteed.' This is false and misleading. The fund has no guarantee, and the 8.2% figure is not the 10-year annualised return of 4.1%. A guarantee claim is a serious breach because it misstates risk.
The five-best-years chart. This is cherry-picked past performance. Marketing must present performance fairly and not select only favourable periods. It should show standardised periods and include a warning that past performance does not predict future results.
'Capital protected by our trustee.' The trustee safeguards assets and oversees the fund; it does not guarantee capital or protect against market loss. This statement confuses custody with a capital guarantee.
'0% entry charge' funded by a 1.5% annual distribution fee. The fee is a material cost and must be disclosed clearly and prominently, not in a 6-point footnote. The headline can mislead investors into thinking the product is free.
'Offer ends 30 September.' The deadline must be genuine. If the offer is routinely extended, the statement is misleading. The 'award-winning team' claim also needs substantiation.
2. What changes must be made before the compliance officer can approve the material?
Read the worked answer
The guarantee claim must be removed entirely. The performance section must show complete, standardised performance for the required periods, with a prominent warning that past performance is not a guide to future returns. The five-best-years chart should be replaced or accompanied by full-period data.
The capital protection claim must be removed or rewritten to explain accurately what the trustee does. The 0% entry charge must be presented with the 1.5% annual distribution fee in the same visual field, in legible type, so that the investor sees the total cost. If the offer deadline is not genuine, it must be removed; if it is genuine, the terms must be stated.
The celebrity endorsement needs due diligence. The draft must not imply that the athlete has investment expertise or that his involvement makes the fund safe. Any paid endorsement should be disclosed. The compliance officer should also check that the award claim can be substantiated and that the overall impression is fair, clear and not misleading.
3. How should the compliance officer handle the 5 p.m. deadline and the celebrity endorsement?
Read the worked answer
The deadline is a commercial pressure, not a compliance reason. The compliance officer should not approve material that is misleading simply because the printer is waiting. The correct response is to refuse approval in writing, list the required changes, and state that the material cannot be used until revised and re-reviewed. If the marketing head proceeds anyway, the compliance officer should escalate to senior management and the trustee, and consider whether the firm's procedures require withdrawal of the material.
On the celebrity endorsement, the compliance officer should require a copy of the endorsement contract, evidence that the athlete understands the product, and disclosure of any payment. The draft should not imply that the athlete invests in the fund unless that is true and documented. The endorsement must not distract from the risk warnings or imply a guarantee. A rushed approval would undermine the compliance function and expose the firm to enforcement and reputational risk.